Showing results (221-230 of 588) with videos related to

Sort By:
Pageof 59
Immunotherapy|June 10, 2017
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studiesChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Expert Opinion on Pharmacotherapy|March 12, 2013
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicineSara Pilotto, Umberto Peretti, Silvia Novello, et al.
Cancers|December 3, 2020
Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant TherapyFilippo Lococo, Carolina Sassorossi, Dania Nachira, et al.
Critical Reviews in Oncology/Hematology|September 2, 2023
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysisLuca Mastrantoni, Viria Beccia, Giulia Caira, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2020
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyMaria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapyJosé Baselga, Karen A Gelmon, Shailendra Verma, et al.
Cancers|February 26, 2025
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' StudyAlessandra Buja, Massimo Rugge, Alberto Bortolami, et al.
Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.
Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.
Critical Reviews in Oncology/Hematology|June 6, 2022
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trialsAlice Avancini, Isabella Sperduti, Anita Borsati, et al.
Pageof 59